Skip to main content
Advertisement
Advertisement

VCRE

VCRE logo

Vicore Pharma Holding AB - ADR

10.35
USD
Sponsored
-0.05
-0.48%
Sep 18, 15:59 UTC -4
Closed
exchange

After-Market

10.41

+0.06
+0.58%

VCRE Earnings Reports

Positive Surprise Ratio

VCRE beat 1 of 2 last estimates.

50%

Next Report

Date of Next Report
Nov 05, 2026
Estimate for Q3 26 (Revenue/ EPS)
$574.26K
/
-$0.49
Implied change from Q2 26 (Revenue/ EPS)
-74.05%
/
-3.92%
Implied change from Q3 25 (Revenue/ EPS)
--
/
+2.08%

Vicore Pharma Holding AB - ADR earnings per share and revenue

On Aug 21, 2026, VCRE reported earnings of -0.51 USD per share (EPS) for Q2 26, missing the estimate of -0.45 USD, resulting in a -11.11% surprise. Revenue reached 2.21 million, compared to an expected 546.72 thousand, with a 304.78% difference. The market reacted with a +4.17% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -0.49 USD, with revenue projected to reach 574.26 thousand USD, implying an decrease of -3.92% EPS, and decrease of -74.05% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Imperial Petroleum Inc. 8.75% Series A Cumulative Redeemable Perpetual Preferred Shares
Report Date
Sep 10, 2026 For Q2 26
Estimate
$0.74
Actual
$0.70
Surprise
-5.99%
FAQ
For Q2 2026, Vicore Pharma Holding AB - ADR reported EPS of -$0.51, missing estimates by -11.11%, and revenue of $2.21M, 304.78% above expectations.
The stock price moved up 4.17%, changed from $12.00 before the earnings release to $12.50 the day after.
The next earning report is scheduled for Nov 05, 2026.
Based on -- analysts, Vicore Pharma Holding AB - ADR is expected to report EPS of -$0.49 and revenue of $574.26K for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement